Reports: Fla. pharmacists hope to administer pneumonia, shingles shots
NEW YORK — Pharmacists in Florida are hoping to expand the kinds of vaccinations they can administer, according to published reports.
Tallahassee, Fla., CBS affiliate WTSP reported that a bill proposed in the state legislature would allow pharmacists to administer shots to prevent pneumonia and shingles. While pharmacists in Florida have been able to administer flu shots since 2007, the state remains one of the few where they can’t administer pneumonia and shingles shots.
A committee in the state House of Representatives voted in favor of the bill, WTSP reported.
Amgen acquiring Micromet for $1.16 billion
THOUSAND OAKS, Calif. — Drug maker Amgen is acquiring a Rockville, Md.-based company developing therapies for cancer, the companies said Thursday.
Amgen announced plans to buy Micromet for $1.16 billion, or $11 per share. Micromet, originally founded in Germany, is developing blinatumomab, currently in phase-2 trials as a treatment for acute lymphoblastic leukemia and non-Hodgkin’s lymphoma. The acquisition also will include the company’s research and development center in Munich.
"The acquisition of Miromet is an opportunity to acquire an innovative oncology asset with global rights, and a validated technology platform with broad potential clinical applications," Amgen chairman and CEO Kevin Sharer said. "Blinatumomab will serve as an important complement to our oncology pipeline and is representative of our corporate strategy, which is focused on developing and successfully commercializing therapeutics to treat patients with grievous illnesses."
Pfizer, J&J subsidiary, charity group launch Alzheimer’s Challenge 2012
NEW YORK — Pfizer is partnering with a division of Johnson & Johnson and a charity organization to launch an initiative to award funding to projects designed to improve the diagnostic identification and tracking of Alzheimer’s disease.
The drug maker said it would work with Janssen Alzheimer Immunotherapy, its partner on the Alzheimer’s Immunotherapy Program, and a subsidiary of J&J and the Geoffrey Beene Gives Back Alzheimer Initiative to introduce the Alzheimer’s Challenge 2012 at the Care Innovations Summit in Washington.
The initiative also will support the Department of Health and Human Services’ call to harness new thinking to deliver better care and better health at lower cost and provide a way to find new ways of thinking and approaches to improve care for people with the disease.
The initiative includes awards totaling $300,000, incorporating $25,000 to five finalists and $175,000 to one winner of the challenge.